Skip to main content
Advertisement
Advertisement

TIL

TIL logo

Instil Bio, Inc. Common Stock

5.91
USD
Sponsored
-0.22
-3.59%
Oct 16, 15:59 UTC -4
Closed
exchange

After-Market

5.95

+0.04
+0.74%

TIL Earnings Reports

Positive Surprise Ratio

TIL beat 8 of 22 last estimates.

36%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.17
Implied change from Q2 26 (Revenue/ EPS)
--
/
-73.02%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-91.50%

Instil Bio, Inc. Common Stock earnings per share and revenue

On Aug 13, 2026, TIL reported earnings of -0.63 USD per share (EPS) for Q2 26, missing the estimate of -0.43 USD, resulting in a -45.06% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.51% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.17 USD, with revenue projected to reach -- USD, implying an decrease of -73.02% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Oct 12, 2026 For Q3 26
Estimate
-$0.61
Actual
$4.73
Surprise
+871.74%
FAQ
For Q2 2026, Instil Bio, Inc. Common Stock reported EPS of -$0.63, missing estimates by -45.06%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.51%, changed from $7.27 before the earnings release to $7.38 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on 4 analysts, Instil Bio, Inc. Common Stock is expected to report EPS of -$0.17 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement